WHO prepares to test new Ebola treatment

The Citizen Media

image

NEW YORK – The World Health Organization announced today from Geneva it is ready to begin implementing the initial phase of testing new Ebola medical therapies and experimental vaccines.

Health facilities are being set up now in Liberia to take blood serum from Ebola survivors for transfusions in the treatment of infected patients. Facilities in Sierra Leone and Guinea will soon follow.

WHO also announced the French government is ready to begin in Guinea clinical trials of a Japanese-developed Ebola vaccine called Favipiravi. Known as T-705, it is marketed by Toyama Chemical under the trade name Avigan.

WHO also announced human Phase 1 clinical trials of two experimental Ebola vaccines are expected to begin by the end of October or the beginning of November.

WHO is ready to test on humans the two frontrunner experimental vaccines it approved in a conference in Geneva Sept. 4-5 with nearly 200 medical doctors…

View original post 110 more words

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s